Skip to main content
SpringerLink
Log in

PET in Lymphoma

  • Chapter
PET/CT

  • 1283 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. What are the key statistics for Hodgkin’s disease and non-Hodgkin’s lymphoma? American Cancer Society (www.cancer.org); 2005 Accessed June 2005.

    Google Scholar 

  2. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol 1999;111(1 Suppl 1):S8–S12.

    PubMed  CAS  Google Scholar 

  3. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, sixth edition. New York: Springer-Verlag; 2002.

    Google Scholar 

  4. Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer 2002;94(4):879–888.

    Article  PubMed  Google Scholar 

  5. Shen YY, Kao A, Yen RF. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma. Oncol Rep 2002;9(2):321–325.

    PubMed  Google Scholar 

  6. Bar-Shalom R, Yefremov N, Haim N, et al. Camera-based FDG PET and 67Ga SPECT in evaluation of lymphoma: comparative study. Radiology 2003;227(2):353–360.

    PubMed  Google Scholar 

  7. Spaepen K, Stroobants S, Verhoef G, Mortelmans L. Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients. Eur J Nucl Med Mol Imaging 2003;30Suppl 1:S97–S105.

    Article  PubMed  Google Scholar 

  8. Elstrom R, Guan L, Baker G, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003;101(10):3875–3876.

    Article  PubMed  CAS  Google Scholar 

  9. Friedberg JW, Chengazi V. PET scans in the staging of lymphoma: current status. Oncologist 2003;8(5):438–747.

    Article  PubMed  Google Scholar 

  10. Reske SN, Kotzerke J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, “Onko-PET III”, 21 July and 19 September 2000. Eur J Nucl Med 2001;28(11):1707–1723.

    Article  PubMed  CAS  Google Scholar 

  11. Hueltenschmidt B, Sautter-Bihl ML, Lang O, et al. Whole body positron emission tomography in the treatment of Hodgkin disease. Cancer 2001;91(2):302–310.

    Article  PubMed  CAS  Google Scholar 

  12. Macapinlac HA. The utility of 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and combined positron emission tomography and computed tomography in lymphoma and melanoma. Mol Imaging Biol 2004;6(4):200–207.

    Article  PubMed  Google Scholar 

  13. Reske SN. PET and restaging of malignant lymphoma including residual masses and relapse. Eur J Nucl Med Mol Imaging 2003;30(Suppl 1):S89–S96.

    Article  PubMed  Google Scholar 

  14. Kostakoglu L, Coleman M, Leonard JP, Kuji I, Zoe H, Goldsmith SJ. PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin’s disease. J Nucl Med 2002;43(8):1018–1027.

    PubMed  Google Scholar 

  15. Najjar F, Hustinx R, Jerusalem G, Fillet G, Rigo P. Positron emission tomography (PET) for staging low-grade non-Hodgkin’s lymphomas (NHL). Cancer Biother Radiopharm 2001;16(4):297–304.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Medical University of South Carolina, Charleston, SC, USA

    Ronald B. Workman Jr. MD (Resident)

  2. Duke University Medical Center, Durham, NC, USA

    R. Edward Coleman MD (Professor and Department of Radiology, Director of Nuclear Medicine)

Authors
  1. Ronald B. Workman Jr. MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Edward Coleman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology, Medical University of South Carolina, Charleston, SC, USA

    Ronald B. Workman Jr. MD (Resident) (Resident)

  2. Duke University Medical Center, Durham, NC, USA

    R. Edward Coleman MD (Professor Department of Radiology and Director of Nuclear Medicine) (Professor Department of Radiology and Director of Nuclear Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Workman, R.B., Coleman, R.E. (2006). PET in Lymphoma. In: Workman, R.B., Coleman, R.E. (eds) PET/CT. Springer, New York, NY . https://doi.org/10.1007/978-0-387-38335-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-38335-4_4

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-32166-0

  • Online ISBN: 978-0-387-38335-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation